Skip to main content
. 2021 Nov 4;147(12):1–7. doi: 10.1001/jamaoto.2021.3077

Table 1. Cohort Demographic and Clinical Characteristics (N = 212).

Characteristic No. (%)
Age at diagnosis, y
≤10 23 (11)
>10 189 (89)
Sex
Female 173 (82)
Male 39 (18)
Family history of thyroid cancer 25 (12)
Autoimmune thyroiditisa 67 (32)
Prior radiation exposure 11 (5)
Thyroid cancer predisposing syndromeb 8 (4)
PTC Variant
Classic 147 (69)
Follicular 31 (15)
Diffuse sclerosing 16 (8)
Otherc 18 (8)
T staged
T1 84 (40)
T2 43 (20)
T3 74 (35)
T4 11 (5)
N stage
N0 58 (27)
N1a 60 (28)
N1b ipsilateral 36 (17)
N1b bilateral 58 (27)
M stage
M0 186 (88)
M1 26 (12)
Tumor size, cm
≤1.0 40% (19)
1.1-2.0 70 (33)
2.1-4.0 67 (32)
>4.0 35 (17)
Any multifocal disease predicted on preoperative imaging 60 (28)
Pathology results positive for multifocal disease 57 (95)
Pathology results negative for multifocal disease 3 (5)
Any multifocal disease 98 (46)
Unilateral multifocal disease 25 (12)
Unilateral multifocal disease predicted on preoperative imaging 9 (36)
Bilateral multifocal disease 73 (34)
Bilateral multifocal disease predicted on preoperative imaging 48 (66)

Abbreviation: PTC, papillary thyroid carcinoma.

a

Autoimmune thyroid disease was defined as Hashimoto thyroiditis or Graves disease diagnosed on history or pathology.

b

Thyroid cancer predisposing syndromes include Cowden, DiGeorge, familial adenomatous polyposis, Li-Fraumeni, and multiple endocrine neoplasia type 2A and 2B syndromes.

c

Other PTC variants include cribriform-morular, oncocytic, solid, tall cell, and mixed.

d

Staging according to the American Joint Committee on Cancer, 7th edition.